Jaime Bartushak's Insider Trades & SAST Disclosures

Jaime Bartushak's most recent trade in Citius Oncology Inc. was a trade of 825,000 Common Stock done . Disclosure was reported to the exchange on Sept. 19, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2025 825,000 825,000 - 0 Common Stock
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2025 825,000 825,000 - 0 Common Stock
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2025 825,000 825,000 - 0 Common Stock
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 400,000 400,000 - - Stock Option (Right to Buy)
Citius Pharma Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2024 350,000 350,000 - - Stock Option (Right to Purchase Common Stock)
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 1,400,000 1,400,000 - - Stock Option (Right to Buy)
Citius Oncology Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 466,667 466,667 - - Stock Option (Right to Buy)
Citius Pharma Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2022 300,000 300,000 - - Stock Option (Right to Purchase Common Stock)
Citius Pharma Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2021 300,000 300,000 - - Stock Option (Right to Purchase Common Stock)
Citius Pharma Inc
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jul 2021 100,000 100,000 - - Stock Option (Right to Purchase Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades